The Open Access and Medical Publishing White Paper, titled A Multistakeholder Discussion on Open Access and Medical Publishing, was released during the 15th Annual Meeting of ISMPP, April 15-17, 2019, in National Harbor, MD. The White Paper is the first-ever released by the Society.
"The Open Access White Paper fulfills an important need among the medical publishing community for comprehensive, multistakeholder perspectives on the evolution of open access publishing and its current and anticipated future state," stated Al Weigel, ISMPP President and CEO, who announced its availability at the 15th Annual Meeting.
The White Paper covers a variety of key topics related to open access publishing, such as:
"The Open Access White Paper fulfills an important need among the medical publishing community for comprehensive, multistakeholder perspectives on the evolution of open access publishing and its current and anticipated future state," stated Al Weigel, ISMPP President and CEO, who announced its availability at the 15th Annual Meeting.
The White Paper covers a variety of key topics related to open access publishing, such as:
- Potential benefits and concerns of Plan S in Europe and its requirement that publications resulting from scientific research funded by public grants must be published in compliant open access journals/platforms by January 1, 2020
- Implications of open access for different stakeholders, including academic authors, patients, the pharmaceutical industry, and not-for-profit funders
- Various stakeholder perspectives on the future of open access